Short Interest in NextPlat Corp. (NASDAQ:NXPL) Increases By 84.3%

NextPlat Corp. (NASDAQ:NXPL) was the recipient of a large growth in short interest in March. As of March 13th, there was short interest totaling 955,043 shares, a growth of 84.3% from the February 26th total of 518,283 shares. Approximately 5.7% of the shares of the company are sold short. Based on an average trading volume of 4,872,892 shares, the short-interest ratio is currently 0.2 days.

NextPlat Price Performance

Shares of NASDAQ:NXPL opened at $0.47 on Friday. The company has a market capitalization of $12.76 million, a PE ratio of -1.58 and a beta of 1.26. The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.80 and a current ratio of 3.56. The stock has a fifty day moving average of $0.56 and a 200-day moving average of $0.66. NextPlat has a one year low of $0.41 and a one year high of $1.11.

Hedge Funds Weigh In On NextPlat

A hedge fund recently bought a new stake in NextPlat stock. Citadel Advisors LLC purchased a new position in NextPlat Corp. (NASDAQ:NXPL) during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 48,176 shares of the company’s stock, valued at approximately $40,000. Citadel Advisors LLC owned approximately 0.19% of NextPlat at the end of the most recent quarter. 1.30% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of NextPlat in a research note on Monday, December 22nd. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company presently has a consensus rating of “Sell”.

NextPlat Company Profile

NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.